Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
Open Access
- 1 May 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (9) , 1455-1457
- https://doi.org/10.1086/587106
Abstract
This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscKeywords
This publication has 12 references indexed in Scilit:
- Multidrug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus IsolatesAntimicrobial Agents and Chemotherapy, 2007
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivoAntiviral Research, 2006
- Human Cytomegalovirus Resistance to Antiviral DrugsAntimicrobial Agents and Chemotherapy, 2005
- Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantationPediatric Transplantation, 2004
- Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugsHuman Immunology, 2004
- Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCRJournal of Clinical Microbiology, 2004
- Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected SubjectsAntimicrobial Agents and Chemotherapy, 2003
- Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipientsBlood, 2003
- Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegalovirusesJournal of Molecular Medicine, 2001
- The Dynamics of Human Cytomegalovirus Replication in VivoThe Journal of Experimental Medicine, 1999